Akshat Jain: Key Takeaways from ASH2025: Transformative Therapeutics, Global Insight, and Compassionate Innovation
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:
“What an inspiring week at ASH2025 — the American Society of Hematology annual meeting in Orlando! Every year, this meeting reinforces why hematology is the beating heart of translational medicine. A few key takeaways that deeply resonated:
Transformative Therapeutics: The science behind novel agents continues to redefine how we treat human disease. The precision and creativity developed in blood disorders are now paving the way for breakthroughs across cancer, autoimmune, and metabolic diseases — a thrilling horizon for modern medicine.
Bench to Bedside in Action: Seeing how complex, chronic, and rare diseases are being approached with structured, risk-adapted protocols reminds me how rigor and compassion come together in true clinical innovation.
Industry: bouncing off ideas , laying Foundation for new collaborations and learning about pipeline always invigorate me.
Global Health Perspective: Hearing insights from colleagues across Europe, Asia, Africa, and beyond was humbling. The diversity in strategy, resource utilization, and patient response reminds us that innovation thrives when we listen, learn, and adapt globally.
Community and Collaboration: The best part — reconnecting with mentors, peers, and new collaborators. The exchange of ideas and the spark of potential partnerships always reignite my passion for research and patient care.
Grateful to be part of a field where discovery meets compassion every single day.
Thank you Andrea Fischer for keeping us informed and an amazing meeting.
Hemostasis Today, American Society of Clinical Oncology (ASCO), Blood Journals Portfolio bringing out timely reading.”
Stay updated with ASH25 updates with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering